☆FCPM III SERVICES B.V.
Quality Q
0.897
AUM ($M)
750
Positions
11
Turnover
0.11
Top-10 wt
100%
Herfindahl
0.207
History (qtrs)
6
Excess Return
-23.6%
AI Eval Run AI Eval
Holdings · 11 positions · portfolio value $750M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | TRIM | — | 38.3% | -2.4% | 287.7 | 8,490,353 | -708,547 | 5 | — |
| ☆MPLT funds › | MAPLIGHT THERAPEUTICS INC | HOLD | Common Stock | 15.4% | +6.3% | 115.6 | 3,226,400 | +0 | 3 | -43.2% |
| ☆DYN funds › | DYNE THERAPEUTICS INC | TRIM | Common Stock | 11.4% | -0.3% | 85.5 | 3,848,256 | -796,130 | 5 | — |
| ☆VOR funds › | VOR BIOPHARMA INC | HOLD | Common Stock | 10.1% | -0.1% | 75.8 | 4,117,354 | +0 | 4 | -68.4% |
| ☆DMRA funds › | DAMORA THERAPEUTICS INC | HOLD | — | 8.5% | -0.3% | 63.5 | 2,441,000 | +0 | 2 | -23.6% |
| ☆REPL funds › | REPLIMUNE GROUP INC | HOLD | Common Stock | 4.1% | +1.2% | 31.1 | 2,808,368 | +0 | 5 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | HOLD | — | 4.0% | -0.2% | 30.2 | 1,677,852 | +0 | 3 | +19.8% |
| ☆AURA funds › | AURA BIOSCIENCES INC | NEW | Common Stock | 3.8% | +3.8% | 28.8 | 4,053,775 | +4,053,775 | 1 | -11.5% |
| ☆CUSIP:29286M105 funds › | ENGENE HOLDINGS INC | HOLD | — | 2.2% | -6.9% | 16.7 | 9,632,561 | +0 | 5 | — |
| ☆BCYC funds › | BICYCLE THERAPEUTICS PLC | HOLD | ADR | 2.0% | -0.3% | 14.7 | 3,468,430 | +0 | 5 | — |
| ☆CUSIP:29286M113 funds › | ENGENE HOLDINGS INC | HOLD | — | 0.1% | -0.9% | 0.8 | 2,878,148 | +0 | 5 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 750 | 11 | 0.11 | 100% | 0.207 | 0.896 | — | in |
| 2026Q1 | 722 | 10 | 0.16 | 100% | 0.218 | 0.856 | — | in |
| 2025Q4 | 763 | 10 | 0.20 | 100% | 0.231 | 0.783 | — | in |
| 2025Q3 | 500 | 9 | 0.08 | 100% | 0.320 | 0.881 | — | in |
| 2025Q2 | 369 | 8 | 0.03 | 100% | 0.319 | 0.916 | — | entered |
| 2025Q1 | 414 | 7 | 0.00 | 100% | 0.339 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status